Home›Clinical trials›Minnesota

GLP-1 clinical trials in Minnesota: 19 recruiting now

26 sites in 6 Minnesota cities. Registry checked October 16, 2026.

Screening for a study can take weeks. Two cash programs to check.

No insurance needed.

  1. SnagRx$99 a monthcompounded semaglutideCheck price →SnagRx's homepage shows its 12-month prepaid prices first
  2. Medvi$299 a monthFirst month $179compounded semaglutideCheck price →Straight to MEDVi's GLP-1 sign-up

Weight-loss studies (5)

Weight-loss study of orforglipron

Where: Minneapolis, Rochester and Saint Paul

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.

Free to join

Who can join: Children and teens 6 to 17 with obesity.

Call the site: 612-625-3623Study record on ClinicalTrials.gov

University of Minnesota Masonic Children's Hospital, Minneapolis. 612-625-3623

Mayo Clinic - PIN, Rochester. 507-538-7804

Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul. 651-220-5730

Weight-loss study of tirzepatide

Where: Minneapolis, Rochester and Saint Paul

What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.

Free to join

Who can join: Children and teens 6 to 11 with obesity.

Call the site: 612-625-3623Study record on ClinicalTrials.gov

University of Minnesota Masonic Children's Hospital, Minneapolis. 612-625-3623

Mayo Clinic - PIN, Rochester. 507-538-7804

Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul. 651-220-5730

Weight-loss study of cagrilintide

Where: Minneapolis and Richfield

What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.

Free to join

Who can join: Children and teens 8 to 18 who are overweight.

Study record on ClinicalTrials.gov

University of Minnesota, Minneapolis

Synexus Clinical Research US-MN, Richfield

Show 2 more studies

Weight-loss study of cagrisema

Where: Minneapolis and Richfield

What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lose weight.

Free to join

Who can join: Adults 18+ with obesity, BMI 35+.

Study record on ClinicalTrials.gov

International Diabetes Center, Minneapolis

AES Minneapolis DRS, Richfield

Type 2 diabetes studies (2)

Type 2 diabetes study of semaglutide

Where: Minneapolis

What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Study record on ClinicalTrials.gov

Research Site, Minneapolis

Type 2 diabetes study of survodutide

Where: Minneapolis

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people with type 2 diabetes lower blood sugar.

Free to join

Who can join: Adults 18+ with type 2 diabetes, BMI 23+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

International Diabetes Center, Minneapolis. 833-602-2368

Other GLP-1 studies in Minnesota (12)

Fatty liver disease with liver scarring study of survodutide

Where: Minneapolis

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).

Call the site: 833-602-2368Study record on ClinicalTrials.gov

MNGI Digestive Health, PA, Minneapolis. 833-602-2368

Fatty liver disease (also called MASH or NASH) study of survodutide

Where: Minneapolis

What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.

Call the site: 833-602-2368Study record on ClinicalTrials.gov

MNGI Digestive Health, PA, Minneapolis. 833-602-2368

Fatty liver disease (MASLD) study of retatrutide

Where: Minneapolis

What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.

Free to join

Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.

Study record on ClinicalTrials.gov

MNGI Digestive Health, Minneapolis

Show 9 more studies

Alcohol use disorder study of semaglutide

Where: Minneapolis

What: Tests whether a GLP-1 medicine, semaglutide, can help people with alcohol use disorder drink less.

Free to join

Who can join: Adults 18 to 80 with alcohol use disorder, BMI 21+.

Call the site: 6124671580Study record on ClinicalTrials.gov

Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis. 6124671580

Prehypertension study of orforglipron

Where: Maplewood

What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people with prediabetes lose weight.

Free to join

Who can join: Adults 18+ who are overweight, BMI 25+.

Study record on ClinicalTrials.gov

Headlands Research-Twin Cities, Maplewood

Fatty liver disease with liver scarring study of tirzepatide

Where: Rochester

What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people reduce liver fat.

Free to join

Who can join: Adults 18 to 75 with fatty liver disease (MASLD) with liver scarring (fibrosis), BMI 35+.

Study record on ClinicalTrials.gov

Mayo Clinic, Rochester

Source: ClinicalTrials.gov, the federal registry, read October 16, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.

Clinical trials by state

Every state with a GLP-1 study recruiting today. 48 of them.

Written and edited by GLP ChartAbout this siteContact
Why you can trust GLP Chart. Same scoring framework applied to every program, and payment never changes a score. We never remove unfavorable information at an advertiser's request. Pricing is pulled from each program's public-facing page every Monday.